Changchun Deng

2.9k total citations
75 papers, 1.8k citations indexed

About

Changchun Deng is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Changchun Deng has authored 75 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 30 papers in Pathology and Forensic Medicine and 22 papers in Oncology. Recurrent topics in Changchun Deng's work include Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (17 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Changchun Deng is often cited by papers focused on Lymphoma Diagnosis and Treatment (30 papers), Chronic Lymphocytic Leukemia Research (17 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). Changchun Deng collaborates with scholars based in United States, China and Canada. Changchun Deng's co-authors include Owen A. O’Connor, J. Martin Brown, James A. L. Brown, Bei-Qing Pan, William S. Saunders, Jennifer E. Amengual, Peter Sportelli, Hari P. Miskin, John G. Kuhn and Ahmed Sawas and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Changchun Deng

70 papers receiving 1.8k citations

Peers

Changchun Deng
Luís Lombardía Spain
Dido Lenze Germany
Javeed Iqbal United States
John Hozier United States
Christian Rudolph Germany
Harry Ratrie United States
Augusto F. Lois United States
Timothy J. O’Brien United States
Angelo Abbondandolo Italy
Qishen Pang United States
Luís Lombardía Spain
Changchun Deng
Citations per year, relative to Changchun Deng Changchun Deng (= 1×) peers Luís Lombardía

Countries citing papers authored by Changchun Deng

Since Specialization
Citations

This map shows the geographic impact of Changchun Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changchun Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changchun Deng more than expected).

Fields of papers citing papers by Changchun Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changchun Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changchun Deng. The network helps show where Changchun Deng may publish in the future.

Co-authorship network of co-authors of Changchun Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Changchun Deng. A scholar is included among the top collaborators of Changchun Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changchun Deng. Changchun Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Chenguang, Yuwen Wang, Jinwei Qiang, et al.. (2025). SOX plus sintilimab vs P-SOX vs SOX as neoadjuvant therapy in advanced gastric cancer: Efficacy and safety. World Journal of Gastrointestinal Oncology. 17(8). 109646–109646.
2.
Deng, Changchun, Paolo F. Caimi, Umar Farooq, et al.. (2024). Phase I Study Results of UF-Kure19, a CAR-T Product Manufactured in Less Than 1 Day, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma. Blood. 144(Supplement 1). 94–94. 1 indexed citations
3.
4.
Pal, Ipsita, et al.. (2019). Targeting Translation of mRNA as a Therapeutic Strategy in Cancer. Current Hematologic Malignancy Reports. 14(4). 219–227. 33 indexed citations
5.
Chen, Yamei, et al.. (2018). Microclimate exerts greater control over litter decomposition and enzyme activity than litter quality in an alpine forest-tundra ecotone. Scientific Reports. 8(1). 14998–14998. 31 indexed citations
6.
Sawas, Ahmed, Charles M. Farber, Marshall T. Schreeder, et al.. (2017). A phase 1/2 trial of ublituximab, a novel anti‐ CD 20 monoclonal antibody, in patients with B‐cell non‐Hodgkin lymphoma or chronic lymphocytic leukaemia previously exposed to rituximab. British Journal of Haematology. 177(2). 243–253. 61 indexed citations
7.
Amengual, Jennifer E., Jennifer Kimberly Lue, Ahmed Sawas, et al.. (2017). A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma. Blood. 131(4). 397–407. 91 indexed citations
8.
9.
Falchi, Lorenzo, Jennifer Kimberly Lue, Jennifer E. Amengual, et al.. (2017). A Phase 1/2 Study of Oral 5-Azacitidine and Romidepsin in Patients with Lymphoid Malignancies Reveals Promising Activity in Heavily Pretreated Peripheral T-Cell Lymphoma (PTCL). Blood. 130. 1515–1515. 10 indexed citations
10.
Jain, Salvia, Kelly Zullo, Luigi Scotto, et al.. (2015). Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma. Clinical Cancer Research. 21(9). 2096–2106. 49 indexed citations
11.
Deng, Changchun, et al.. (2015). [Relationships between decomposition rate of leaf litter and initial quality across the alpine timberline ecotone in Western Sichuan, China].. PubMed. 26(12). 3602–10. 7 indexed citations
12.
Amengual, Jennifer E., et al.. (2015). Will new drugs change the standard of care for patients with mantle cell lymphoma?. Expert Review of Anticancer Therapy. 16(2). 199–210. 1 indexed citations
13.
Deng, Changchun, Richard Rodríguez, Christine McIntosh, et al.. (2014). The Novel IKK2 Inhibitor LY2409881 Potently Synergizes with Histone Deacetylase Inhibitors in Preclinical Models of Lymphoma through the Downregulation of NF-κB. Clinical Cancer Research. 21(1). 134–145. 21 indexed citations
14.
Song, Xiaoyan, Danju Zhang, Jian Zhang, et al.. (2014). [Effects of gaps on distribution of soil aggregates and organic carbon in Pinus massoniana plantation].. PubMed. 25(11). 3083–90. 1 indexed citations
15.
Chen, Yamei, et al.. (2014). Litter cellulolytic enzyme activities in alpine timberline ecotone of western Sichuan. Chinese Journal of Plant Ecology. 38(4). 334–342. 2 indexed citations
16.
Patel, Bhavesh, Yuanyuan Kang, Michael D. Litt, et al.. (2013). Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia. Leukemia. 28(2). 349–361. 48 indexed citations
17.
18.
Yuan, Honglin, et al.. (2009). Flavobacterium cauense sp. nov., isolated from sediment of a eutrophic lake. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY. 59(11). 2666–2669. 31 indexed citations
19.
Kanna, Balavenkatesh, et al.. (2006). The research rotation: competency-based structured and novel approach to research training of internal medicine residents. BMC Medical Education. 6(1). 52–52. 76 indexed citations
20.
Haugen, Astrid C., Ryan Kelley, Jennifer B. Collins, et al.. (2004). Integrating phenotypic and expression profiles to map arsenic-response networks. Genome biology. 5(12). R95–R95. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luís Lombardía Breakdown of academic impact, for papers by Dido Lenze Breakdown of academic impact, for papers by Javeed Iqbal Breakdown of academic impact, for papers by John Hozier Breakdown of academic impact, for papers by Christian Rudolph Breakdown of academic impact, for papers by Harry Ratrie Breakdown of academic impact, for papers by Augusto F. Lois Breakdown of academic impact, for papers by Timothy J. O’Brien Breakdown of academic impact, for papers by Angelo Abbondandolo Breakdown of academic impact, for papers by Qishen Pang
Rankless by CCL
2026